DENTSPLY SIRONA Inc. provided earnings guidance for second quarter 2022. For the period, The company expects net sales of greater than $1,005 million. Additionally, diluted EPS is expected to be at or above $0.26.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
30.36 USD | -1.40% | -6.27% | -14.70% |
Apr. 03 | DENTSPLY SIRONA Inc.(NasdaqGS:XRAY) added to S&P 1000 | CI |
Apr. 03 | DENTSPLY SIRONA Inc.(NasdaqGS:XRAY) added to S&P 400 Health Care | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-14.70% | 6.39B | |
-4.01% | 105B | |
-4.77% | 66.74B | |
+7.87% | 52.63B | |
+16.18% | 47.48B | |
+0.51% | 39.68B | |
+7.17% | 27.78B | |
-1.23% | 26.27B | |
+3.80% | 26.11B | |
+10.56% | 25.38B |
- Stock Market
- Equities
- XRAY Stock
- News DENTSPLY SIRONA Inc.
- Dentsply Sirona Inc. Provides Earnings Guidance for Second Quarter 2022